Alcyomics® to Transform Drug Discovery for Osteoarthritis Treatment With Unique In Vitro Bio-Printed 3D Tissue Model.
February 1, 2023
Newcastle upon Tyne, 26 January, 2023. Alcyomics Limited® announces it is seeking partners to participate in validation tests of its unique in vitro 3D bio-printed Osteoarthritis tissue model.
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.